Top

Quality of Life Research

Gepubliceerd in:

05-07-2021 | Review

Health utilities in pediatric cancer patients and survivors: a systematic review and meta-analysis for clinical implementation

Auteurs: Pingyu Chen, Melissa M. Hudson, Minghui Li, I-Chan Huang

Gepubliceerd in: Quality of Life Research | Uitgave 2/2022

Abstract

Purpose

Health utility (HU) is a useful metric for evaluating cost and utility of cancer therapies or prioritizing healthcare resources. We conducted a meta-analysis to compare HUs in association with clinical parameters and identify missing cancer-related themes from the extant HU measures for pediatric cancer patients and survivors.

Methods

Studies published in the PubMed, Embase, Web of Science, and Cochrane Library were identified. Meta-analyses were performed to estimate weighted means of HUs assessed by self- and proxy-responses. Mixed-effects meta-regressions were applied to compare HUs between cancer patients/survivors and general populations. Missing themes in the extant measures were identified based on established patient-reported outcomes frameworks.

Results

Of 123 selected studies included pediatric cancer populations, 44% used the Health Utilities Index version 2 (HUI2), and 48% used version 3 (HUI3). Compared to general populations, cancer patients undergoing therapies for acute lymphoblastic leukemia (ALL) had 0.129 (95% CI − 0.183 to − 0.075) and brain tumor had 0.257 (95% CI − 0.354 to − 0.160) lower HUs per proxy-reported HUI3, whereas survivors of ALL had 0.028 (95% CI − 0.062 to 0.007) and brain tumor had 0.188 (95% CI − 0.237 to − 0.140) lower HUs per proxy-reported HUI3. Compared to general populations, cancer patients treated with multimodality therapy and survivors off therapy 2–5 years had significantly poorer HUs (p’s < 0.05). Missing cancer-specific contents from the HU measures were identified.

Conclusion

Pediatric cancer patients and survivors had poorer HUs than general populations. It is important to select appropriate HUs for economic evaluations, and offer interventions to minimize HU deficits for particular cancer populations.

vorige artikel Self-reported quality of life following stroke: a systematic review of instruments with a focus on their psychometric properties

volgende artikel The impact of acute pneumococcal disease on health state utility values: a systematic review

Alleen toegankelijk voor geautoriseerde gebruikers

Green, D., Galvin, H., & Horne, B. (2003). The psycho-social impact of infertility on young male cancer survivors: A qualitative investigation. Psycho-oncology, 12(2), 141–152.PubMedCrossRef

Hudson, M. M., Ness, K. K., Gurney, J. G., Mulrooney, D. A., Chemaitilly, W., Krull, K. R., Green, D. M., Armstrong, G. T., Nottage, K. A., Jones, K. E., Sklar, C. A., Srivastava, D. K., & Robison, L. L. (2013). Clinical ascertainment of health outcomes among adults treated for childhood cancer. Jama, 309(22), 2371–2381.PubMedPubMedCentralCrossRef

Huang, I. C., Brinkman, T. M., Kenzik, K., Gurney, J. G., Ness, K. K., Lanctot, J., Shenkman, E., Robison, L. L., Hudson, M. M., & Krull, K. R. (2013). Association between the prevalence of symptoms and health-related quality of life in adult survivors of childhood cancer: A report from the St Jude Lifetime Cohort study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 31(33), 4242–4251.CrossRef

Robison, L. L., & Hudson, M. M. (2014). Survivors of childhood and adolescent cancer: Life-long risks and responsibilities. Nature Reviews Cancer, 14(1), 61–70.PubMedCrossRef

Phillips, S. M., Padgett, L. S., Leisenring, W. M., Stratton, K. K., Bishop, K., Krull, K. R., Alfano, C. M., Gibson, T. M., de Moor, J. S., Hartigan, D. B., Armstrong, G. T., Robison, L. L., Rowland, J. H., Oeffinger, K. C., & Mariotto, A. B. (2015). Survivors of childhood cancer in the United States: Prevalence and burden of morbidity. Cancer Epidemiology Biomarkers & Prevention, 24(4), 653–663.CrossRef

Armstrong, G. T., Chen, Y., Yasui, Y., Leisenring, W., Gibson, T. M., Mertens, A. C., Stovall, M., Oeffinger, K. C., Bhatia, S., Krull, K. R., Nathan, P. C., Neglia, J. P., Green, D. M., Hudson, M. M., & Robison, L. L. (2016). Reduction in late mortality among 5-year survivors of childhood cancer. The New England Journal of Medicine, 374(9), 833–842.PubMedPubMedCentralCrossRef

Varni, J. W., & Limbers, C. A. (2009). The pediatric quality of life inventory: Measuring pediatric health-related quality of life from the perspective of children and their parents. Pediatric Clinics of North America, 56(4), 843–863.PubMedCrossRef

Varni, J. W., Burwinkle, T. M., & Lane, M. M. (2005). Health-related quality of life measurement in pediatric clinical practice: An appraisal and precept for future research and application. Health Quality of Life Outcomes, 3(1), 34.PubMedPubMedCentralCrossRef

Varni, J. W., Seid, M., & Kurtin, P. S. (2001). PedsQL™ 4.0: Reliability and validity of the Pediatric Quality of Life Inventory™ Version 4.0 Generic Core Scales in healthy and patient populations. Medical Care, 39(8), 800–812.PubMedCrossRef

10.

Cella, D., Yount, S., Rothrock, N., Gershon, R., Cook, K., Reeve, B., Ader, D., Fries, J. F., Bruce, B., & Rose, M. (2007). The Patient-Reported Outcomes Measurement Information System (PROMIS): Progress of an NIH Roadmap cooperative group during its first two years. Medical Care, 45(5 Suppl 1), S3.PubMedPubMedCentralCrossRef

11.

Landgraf, J., Maunsell, E., Speechley, K. N., Bullinger, M., Campbell, S., Abetz, L., & Ware, J. (1998). Canadian-French, German and UK versions of the Child Health Questionnaire: Methodology and preliminary item scaling results. Quality of Life Research, 7(5), 433–445.PubMedCrossRef

12.

Waldeck, A. R., Botteman, M. F., White, R. E., & van Hout, B. A. (2017). The importance of economic perspective and quantitative approaches in oncology value frameworks of drug selection and shared decision making. Journal of Managed Care & Specialty Pharmacy, 23(Suppl), S6–S12.CrossRef

13.

Seymour, E. K., Schiffer, C. A., & de Souza, J. A. (2017). Challenges in the clinical application of the American Society of Clinical Oncology Value Framework: A medicare cost-benefit analysis in chronic lymphocytic leukemia. Journal of Oncology Practice, 13(12), e1002–e1011.PubMedCrossRef

14.

Shah-Manek, B., Wong, W., Ravelo, A., & DiBonaventura, M. (2018). Oncologists’ perceptions of drug affordability using NCCN evidence blocks: Results from a national survey. Journal of Managed Care & Specialty Pharmacy, 24(6), 565–571.CrossRef

15.

Pearson, S. D. (2018). The ICER value framework: Integrating cost effectiveness and affordability in the assessment of health care value. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 21(3), 258–265.CrossRef

16.

Ungar, W. J. (2011). Challenges in health state valuation in paediatric economic evaluation. PharmacoEconomics, 29(8), 641–652.PubMedCrossRef

17.

Torrance, G. W., Furlong, W., Feeny, D., & Boyle, M. (1995). Multi-attribute preference functions. PharmacoEconomics, 7(6), 503–520.PubMedCrossRef

18.

Wille, N., Badia, X., Bonsel, G., Burström, K., Cavrini, G., Devlin, N., Egmar, A.-C., Greiner, W., Gusi, N., & Herdman, M. (2010). Development of the EQ-5D-Y: A child-friendly version of the EQ-5D. Quality of Life Research, 19(6), 875–886.PubMedPubMedCentralCrossRef

19.

Stevens, K. (2009). Developing a descriptive system for a new preference-based measure of health-related quality of life for children. Quality of Life Research, 18(8), 1105–1113.PubMedCrossRef

20.

Chen, G., & Ratcliffe, J. (2015). A review of the development and application of generic multi-attribute utility instruments for paediatric populations. PharmacoEconomics, 33(10), 1013–1028.PubMedCrossRef

21.

Fardell, J. E., Vetsch, J., Trahair, T., Mateos, M. K., Grootenhuis, M. A., Touyz, L. M., Marshall, G. M., & Wakefield, C. E. (2017). Health-related quality of life of children on treatment for acute lymphoblastic leukemia: A systematic review. Pediatric Blood & Cancer, 64(9), 1–13.CrossRef

22.

Macartney, G., Harrison, M. B., VanDenKerkhof, E., Stacey, D., & McCarthy, P. (2014). Quality of life and symptoms in pediatric brain tumor survivors: A systematic review. Journal of Pediatric Oncology Nursing: Official Journal of the Association of Pediatric Oncology Nurses, 31(2), 65–77.CrossRef

23.

Pickard, A. S., Topfer, L. A., & Feeny, D. H. (2004). A structured review of studies on health-related quality of life and economic evaluation in pediatric acute lymphoblastic leukemia. Journal of the National Cancer Institute. Monographs, 33, 102–125.CrossRef

24.

Schulte, F., Russell, K. B., Cullen, P., Embry, L., Fay-McClymont, T., Johnston, D., Rosenberg, A. R., & Sung, L. (2017). Systematic review and meta-analysis of health-related quality of life in pediatric CNS tumor survivors. Pediatric Blood & Cancer, 64(8), 1–9.CrossRef

25.

Vetsch, J., Wakefield, C. E., Robertson, E. G., Trahair, T. N., Mateos, M. K., Grootenhuis, M., Marshall, G. M., Cohn, R. J., & Fardell, J. E. (2018). Health-related quality of life of survivors of childhood acute lymphoblastic leukemia: A systematic review. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 27(6), 1431–1443.CrossRef

26.

Kwon, J., Kim, S. W., Ungar, W. J., Tsiplova, K., Madan, J., & Petrou, S. (2018). A systematic review and meta-analysis of childhood health utilities. Medical Decision Making, 38(3), 277–305.PubMedCrossRef

27.

Tarride, J. E., Burke, N., Bischof, M., Hopkins, R. B., Goeree, L., Campbell, K., Xie, F., O’Reilly, D., & Goeree, R. (2010). A review of health utilities across conditions common in paediatric and adult populations. Health and Quality of Life Outcomes, 8, 12.PubMedPubMedCentralCrossRef

28.

van Litsenburg, R. R., Kunst, A., Huisman, J., Ket, J. C., Kaspers, G. J., & Gemke, R. J. (2014). Health status utilities in pediatrics: A systematic review of acute lymphoblastic leukemia. Medical Decision Making, 34(1), 21–32.PubMedCrossRef

29.

Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & Group P. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine, 6(7), e1000097.PubMedPubMedCentralCrossRef

30.

Weed, D. L. (2018). The need for systematic reviews in oncology. JNCI: Journal of the National Cancer Institute, 110(8), 812–814.PubMedCrossRef

31.

The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Department of Epidemiology and Community Medicine, University of Ottawa, Canada. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm]

32.

Higgins, J. P., Altman, D. G., Gøtzsche, P. C., Jüni, P., Moher, D., Oxman, A. D., Savović, J., Schulz, K. F., Weeks, L., & Sterne, J. A. (2011). The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ, 343, d5928.PubMedPubMedCentralCrossRef

33.

Higgins, J. P., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003). Measuring inconsistency in meta-analyses. BMJ, 327(7414), 557–560.PubMedPubMedCentralCrossRef

34.

Langeveld, N. E., Stam, H., Grootenhuis, M. A., & Last, B. F. (2002). Quality of life in young adult survivors of childhood cancer. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 10(8), 579–600.CrossRef

35.

Djalalov, S., Rabeneck, L., Tomlinson, G., Bremner, K. E., Hilsden, R., & Hoch, J. S. (2014). A review and meta-analysis of colorectal cancer utilities. Medical Decision Making, 34(6), 809–818.PubMedCrossRef

36.

Garcia, S. F., Cella, D., Clauser, S. B., Flynn, K. E., Lad, T., Lai, J. S., Reeve, B. B., Smith, A. W., Stone, A. A., & Weinfurt, K. (2007). Standardizing patient-reported outcomes assessment in cancer clinical trials: A patient-reported outcomes measurement information system initiative. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 25(32), 5106–5112.CrossRef

37.

Bingham, J. M., Taylor, A. M., Boesen, K. P., & Axon, D. R. (2020). Preliminary investigation of pharmacist-delivered, direct-to-provider interventions to reduce co-prescribing of opioids and benzodiazepines among a medicare population. Pharmacy (Basel), 8(1), 1–11.

38.

Anthony, S. J., Selkirk, E., Sung, L., Klaassen, R. J., Dix, D., & Klassen, A. F. (2017). Quality of life of pediatric oncology patients: Do patient-reported outcome instruments measure what matters to patients? Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 26(2), 273–281.CrossRef

39.

Barr, R. D., Simpson, T., Whitton, A., Rush, B., Furlong, W., & Feeny, D. H. (1999). Health-related quality of life in survivors of tumours of the central nervous system in childhood—A preference-based approach to measurement in a cross-sectional study1Presented in part to the meetings of the International Society of Pediatric Oncology (SIOP) in Paris, September 1994 and Montevideo, October 1995.1. European Journal of Cancer, 35(2), 248–255.PubMedCrossRef

40.

Link, K., Moell, C., Osterberg, K., Persson, R., Orbaek, P., Garwicz, S., Cavallin-Stahl, E., & Erfurth, E. M. (2006). Adult survivors of childhood acute lymphoblastic leukaemia with GH deficiency have normal self-rated quality of life but impaired neuropsychological performance 20 years after cranial irradiation. Clinical Endocrinology, 65(5), 617–625.PubMedCrossRef

41.

Shortman, R. I., Lowis, S. P., Penn, A., McCarter, R. J., Hunt, L. P., Brown, C. C., Stevens, M. C., Curran, A. L., & Sharples, P. M. (2014). Cognitive function in children with brain tumors in the first year after diagnosis compared to healthy matched controls. Pediatric Blood Cancer, 61(3), 464–472.

42.

Nelson, M. B., Compton, P., Patel, S. K., Jacob, E., & Harper, R. (2013). Central nervous system injury and neurobiobehavioral function in children with brain tumors: A review of the literature. Cancer Nursing, 36(2), E31.PubMedCentralCrossRef

43.

Parsons, S. K., Fairclough, D. L., Wang, J., & Hinds, P. S. (2012). Comparing longitudinal assessments of quality of life by patient and parent in newly diagnosed children with cancer: The value of both raters’ perspectives. Quality of Life Research, 21(5), 915–923.PubMedCrossRef

44.

Janse, A., Sinnema, G., Uiterwaal, C., Kimpen, J., & Gemke, R. (2008). Quality of life in chronic illness: Children, parents and paediatricians have different, but stable perceptions. Acta Paediatrica, 97(8), 1118–1124.PubMedCrossRef

45.

Eiser, C., & Morse, R. (2001). Can parents rate their child’s health-related quality of life? Results of a systematic review. Quality of Life Research, 10(4), 347–357.PubMedCrossRef

46.

Hinds, P. S., Nuss, S. L., Ruccione, K. S., Withycombe, J. S., Jacobs, S., DeLuca, H., Faulkner, C., Liu, Y., Cheng, Y. I., & Gross, H. E. (2013). PROMIS pediatric measures in pediatric oncology: Valid and clinically feasible indicators of patient-reported outcomes. Pediatric Blood Cancer, 60(3), 402–408.PubMedCrossRef

47.

DeWalt, D. A., Gross, H. E., Gipson, D. S., Selewski, D. T., DeWitt, E. M., Dampier, C. D., Hinds, P. S., Huang, I.-C., Thissen, D., & Varni, J. W. (2015). PROMIS® pediatric self-report scales distinguish subgroups of children within and across six common pediatric chronic health conditions. Quality of Life Research, 24(9), 2195–2208.PubMedPubMedCentralCrossRef

48.

Hinds, P. S., Wang, J., Cheng, Y. I., Stern, E., Waldron, M., Gross, H., DeWalt, D. A., & Jacobs, S. S. (2019). PROMIS pediatric measures validated in a longitudinal study design in pediatric oncology. Pediatric Blood Cancer Epidemiology, 66(5), e27606.CrossRef

49.

Wang, J., Jacobs, S., Dewalt, D. A., Stern, E., Gross, H., & Hinds, P. S. (2018). A longitudinal study of PROMIS pediatric symptom clusters in children undergoing chemotherapy. Journal of Pain Symptom Management, 55(2), 359–367.PubMedCrossRef

50.

Adlard, N., Kinghorn, P., & Frew, E. (2014). Is the UK NICE “Reference Case” influencing the practice of pediatric quality-adjusted life-year measurement within economic evaluations? Value in Health, 17(4), 454–461.PubMedCrossRef

51.

Wolstenholme, J. L., Bargo, D., Wang, K., Harnden, A., Räisänen, U., & Abel, L. (2018). Preference-based measures to obtain health state utility values for use in economic evaluations with child-based populations: A review and UK-based focus group assessment of patient and parent choices. Quality of Life Research, 27(7), 1769–1780.PubMedPubMedCentralCrossRef

52.

Ratcliffe, J., Huynh, E., Chen, G., Stevens, K., Swait, J., Brazier, J., Sawyer, M., Roberts, R., & Flynn, T. (2016). Valuing the Child Health Utility 9D: Using profile case best worst scaling methods to develop a new adolescent specific scoring algorithm. Social Science and Medicine, 157, 48–59.PubMedCrossRef

53.

Cella, D., Hahn, E. A., & Dineen, K. (2002). Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening. Quality of Life Research, 11(3), 207–221.PubMedCrossRef

54.

Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., & de Haes, J. C. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376.PubMedCrossRef

Titel: Health utilities in pediatric cancer patients and survivors: a systematic review and meta-analysis for clinical implementation
Auteurs: Pingyu Chen
Melissa M. Hudson
Minghui Li
I-Chan Huang
Publicatiedatum: 05-07-2021
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 2/2022
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-021-02931-0

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusion

Log in om toegang te krijgen

Andere artikelen Uitgave 2/2022

The Mental Health Quality of Life Questionnaire (MHQoL): development and first psychometric evaluation of a new measure to assess quality of life in people with mental health problems

Feasibility and performance of smartphone-based daily micro-surveys among patients recovering from cancer surgery

Development of prognostic models for Health-Related Quality of Life following traumatic brain injury

Screening for symptoms of anxiety and depression in patients treated with renal replacement therapy: utility of the Edmonton Symptom Assessment System-Revised

Psychometric examination of short forms from the University of Washington pain-related self-efficacy and concerns about pain item banks in patients with low back pain

Norwegian population norms for the EQ-5D-5L: results from a general population survey